SCD and cancer: In recent studies, FADS2 acted noncanonically to convert the SCD1 substrate palmitate to sapienate in SCD1-independent cancer cells [31,32], highlighting the highly plastic nature of FADS2 and identifying a critical interplay between SCD1 and FADS2 in tumor biology.